Find out if Ultherapy®
is a fit for your practice

In just 15 minutes, an Ultherapy specialist can
demonstrate the unique patient and practice benefits
of this FDA-cleared non-invasive procedure.


Meeting Agenda

  • Technology Overview
  • Financial Analysis & Custom ROI
  • Practice Marketing
  • Product Review

Please answer the following questions:

I am a physician and the financial decision-maker for a practice that offers cosmetic procedures.

I am considering adding a new technology to my practice.


* What brought you here today?

Request a 15 Minute Educational Meeting

*
*
*
*
*
*
*
*
*
×

EM02510-00

Receive updates about the Ultherapy® procedure!

Communication Options

Fields in red indicate information that
needs to be filled out in order to process
your request.

Please select at least one of the following options

Send me email updates

Send me a digital information packet

Include me in promotional mailers

Requires you to supply your full address

Connect me with a nearby practice *

Requires you to supply your full address and phone number

* By selecting this option, you allow Ulthera, Inc. to share your full name, phone number and email address with the practice nearest to the address supplied so they may contact you with more information on Ultherapy.

EM02491-00

By clicking the "Submit" button, you are in agreement with the Privacy Policy and Terms of Use outlined on Ultherapy.com

×

Success!

Your submission is complete. Here's where we recommend you go next:

Before & After Photos Patient Reviews

Ultherapy Results


"The reason I was so excited about Ultherapy is that you can get results without having to have surgery." - Joanne, 58
×
The Ulthera System Is Based On 16+ Years of Rigorous R&D and Clinical Evaluation
+ Expand

Over 16 Years In The Making...

The technology behind Ulthera was created through a research partnership formed in 1998 to develop micro-focused ultrasound for non-invasive treatment of liver cancer. In 2004, Ulthera was established to develop this technology for the aesthetic space. After two years of extensive pre-clinical research, Ulthera conducted 3 clinical studies to evaluate safety and efficacy of the technology. One of these studies, an efficacy study at Northwestern University in 2007, demonstrated a clinically significant brow lift in 89% of the patients treated and led to Ulthera’s first FDA indication. In September 2009, Ulthera was granted de novo 510K clearance from the FDA, designating the device as a new category of non-invasive technology without a comparable predicate. In 2012, the system received an FDA indication for neck and under-chin lift, and in 2013, it received a third FDA indication for visualization of dermal and subdermal tissue layers. Most recently, the system received its fourth FDA indication for improvement of lines and wrinkles on the décolleté.